April 5, 2026 5:46 AM
Latest:
  • Teck Resources Q1 Earnings: Defying Copper Industry Weakness
  • Equinox Ups Its Offer For Calibre: Investors Said No!
  • First Quantum Q1 Earnings: Copper Major Still Bleeding Cash
  • Barrick’s $1 Billion Donlin Gold Sale: Why Everyone Agrees It’s a Win
  • Agnico Eagle Q1 Earnings: Costs Go Down?!
The Deep Dive

the deep dive

Providing stock analysis for investors of the Canadian junior markets

  • Home
  • Latest
    • Automotive
    • Cannabis
    • Commentary
    • Full Analysis
    • Gold
    • Industrials
    • Macro
    • Oil
    • Resources
    • Technology
  • Resources
  • Energy
  • Technology
  • Coverage Companies
    • Brazil Potash
    • Canadian Copper
    • Cardiol Therapeutics
    • Cytophage Technologies
    • ESGold Corp
    • First Majestic Silver
    • Golden Cariboo Resources
    • Nations Royalty Corp
    • Plurilock Security
    • Power Metallic
    • PTX Metals
    • Riverside Resources
    • Rua Gold
    • Silver47 Exploration
    • Sonoro Gold
    • Spirit Blockchain
    • Temas Resources
  • Verses AI
  • About
  • Contact Us

Cronos Group

Cannabis Latest 

Cronos Group Sees Revenues Stay Flat In First Quarter Versus Q4, Margins Improve

May 10, 2022 7:53 AMMay 10, 2022 7:54 AM Jay Lutz 0 Comments Cronos Group

Cronos Group (TSX: CRON) this morning posted its first quarter financial results for 2022. Surprisingly, the company appears to be

Share
Tweet
Share
Reddit
Read more
Cannabis Latest 

Cronos Group Sees CEO Retire, Gorenstein Returns To Helm

March 21, 2022 8:32 AMMarch 21, 2022 8:32 AM Jay Lutz 0 Comments Cronos Group

After less than two years on the job, Kurt Schmidt has retired as the chief executive officer of Cronos Group

Share
Tweet
Share
Reddit
Read more
Cannabis Latest 

Cronos Group: Canaccord Reiterates Sell Rating Follow Q4 2021 Results

March 2, 2022 3:42 PMMarch 2, 2022 3:31 PM Justin Young 0 Comments Analyst Estimate, Cronos Group

Yesterday, Cronos Group (TSX: CRON) reported their fourth-quarter and full-year financial results. The company reported revenues of $25.8 million for

Share
Tweet
Share
Reddit
Read more
Cannabis Latest 

Cronos Group To Close Canadian Facility, Reports Q4 Net Loss Of $133.9 Million

March 1, 2022 8:48 AMMarch 1, 2022 8:48 AM Jay Lutz 0 Comments Cronos Group

Cronos Group (TSX: CRON) appears to be finally taking steps to address its absolute lack of ability to generate any

Share
Tweet
Share
Reddit
Read more
Cannabis Latest 

Cronos Group Finally Files Q3 Results, Announces Business Realignment

February 18, 2022 8:09 AMFebruary 18, 2022 8:11 AM Jay Lutz 0 Comments Cronos Group

It may be more than three months later than initially expected, but Cronos Group (TSX: CRON) this morning finally released

Share
Tweet
Share
Reddit
Read more
Cannabis Latest 

Cronos Group Delays Q3 2021 Results Again, Now Due To Be Filed By February 18

January 30, 2022 2:37 PMJanuary 30, 2022 2:37 PM Jay Lutz 0 Comments Cronos Group

Cronos Group (TSX: CRON) (NASDAQ: CRON) by all accounts appears unable to get a firm hold on its financial results.

Share
Tweet
Share
Reddit
Read more
Cannabis Latest 

Cronos Group Doesn’t Expect To File Delayed Financials Until The End Of January 2022

December 20, 2021 9:17 AMDecember 20, 2021 9:18 AM Jay Lutz 0 Comments Cronos Group

It appears that money is no substitute for ability. Cronos Group (TSX: CRON) on Friday night provided its bi-weekly management

Share
Tweet
Share
Reddit
Read more
Cannabis Latest 

Cronos Group Licenses IP From Aurora Cannabis, 22nd Century Group Related To Biosynthesis

December 15, 2021 9:21 AMDecember 15, 2021 9:16 AM Jay Lutz 0 Comments 22nd Century Group, Aurora Cannabis, Cronos Group

Aurora Cannabis (TSX:ACB) has reportedly entered into a licensing arrangement with 22nd Century Group (NASDAQ: XXII) and Cronos Group (TSX:

Share
Tweet
Share
Reddit
Read more
Cannabis Latest 

Cronos Group Receives Delinquency Letter From Nasdaq

November 22, 2021 8:52 AMNovember 22, 2021 8:52 AM Jay Lutz 0 Comments Cronos Group

Cronos Group (TSX: CRON) on Friday after hours provided a bi-weekly management cease trade update in connection with its delayed

Share
Tweet
Share
Reddit
Read more
Cannabis Latest 

Cronos Group Delays Financials Due To At Least $220 Million In Goodwill, Intangible Asset Impairments

November 9, 2021 7:50 AMNovember 9, 2021 7:50 AM Jay Lutz 0 Comments Cronos Group

While some people are currently speculating that Cronos Group (TSX: CRON) hasn’t announced a filing date for its latest set

Share
Tweet
Share
Reddit
Read more
  • ← Previous
  • Next →

Latest

  • Teck Resources Q1 Earnings: Defying Copper Industry Weakness

  • Equinox Ups Its Offer For Calibre: Investors Said No!

  • First Quantum Q1 Earnings: Copper Major Still Bleeding Cash

  • Barrick’s $1 Billion Donlin Gold Sale: Why Everyone Agrees It’s a Win

  • Agnico Eagle Q1 Earnings: Costs Go Down?!

  • Why Gold Is Secretly Flooding Into The U.S. & Who’s Suppressing Silver?! | Andy Schectman

  • Gold @ $3500: All We Need Is $700 To Break Even! | Brad Kitchen – ESGOLD Corp.

  • Canada Is Nearly Last In Growth Among OECD Countries

Video

Teck Resources Q1 Earnings: Defying Copper Industry Weakness
Full Analysis Latest Resources Video Series 

Teck Resources Q1 Earnings: Defying Copper Industry Weakness

April 27, 2025 4:40 PM Jay Lutz 0

Yesterday in our coverage of First Quantum Mining’s business we said it was a terrible time to be a copper

Trending

  • Annie Altman, OpenAI CEO's Sister, Tweets About Sexual Abuse Suffered From "Brother" Sam Altman
  • Filament Health Walks Away From SPAC Merger, US$14.4 Million Financing
  • Commodities And The New World Order: What You Need To Know From Zoltan Pozsar's Bretton Woods III
  • X Changes Policy to Now Allow Adult Content
  • Trudeau’s Decision to Sell Canada’s Gold Reserves Has Now Cost Canada Over $149 million

News

Cardiol Sees First Patient Enrolled Under Phase III MAVERIC Clinical Trial
Biotech Latest News 

Cardiol Sees First Patient Enrolled Under Phase III MAVERIC Clinical Trial

April 17, 2025 7:59 AM Jay Lutz 0

Cardiol Therapeutics (TSX: CRDL) has reached a major milestone with the announcement that the first patients have been enrolled into a phase III clinical trial for its lead drug candidate, CardiolRx™.

Rua Gold Hits 13.3 g/t Gold, 8.1% Antimony Over 1.25 Metres At Auld Creek
Latest News Resources 

Rua Gold Hits 13.3 g/t Gold, 8.1% Antimony Over 1.25 Metres At Auld Creek

April 16, 2025 8:29 AM Jay Lutz 0
Canadian Copper To Begin Exploration At Murray Brook East
Latest News Resources 

Canadian Copper To Begin Exploration At Murray Brook East

April 15, 2025 10:30 AM Jay Lutz 0

About

Welcome to The Deep Dive, where we focus on providing investors of Canadian junior stock markets the knowledge they need to make smart investment decisions. We take a closer look at all data relating to organizations listed on the CSE and the TSX Venture to create quality stock analysis for investors.

Not a recommendation to buy or sell securities. Always do additional research and consult a professional before purchasing a security.

Menu

  • Home
  • About
  • Research
  • Discover
  • Contact Us
  • Disclaimer

Categories

  • Automotive
  • Biotech
  • Bonds
  • Cannabis
  • Commentary
  • Crypto
  • Education
  • Energy
  • Entertainment
  • Esports
  • ETFs
  • Food
  • Full Analysis
  • Healthcare
  • Industrials
  • Latest
  • Lithium
  • Macro
  • Market Movers
  • Mental Hurdles
  • News
  • Oil
  • Politics
  • Psychedelics
  • Real Estate
  • Resources
  • Retail
  • SPACs
  • Technology
  • Video Series
Copyright © 2026 the deep dive. All rights reserved.
Theme: ColorMag by ThemeGrill. Powered by WordPress.